[1]
Lenting PJ,Christophe OD,Denis CV, von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends. Blood. 2015 Mar 26;
[PubMed PMID: 25712991]
[2]
Peyvandi F,Garagiola I,Baronciani L, Role of von Willebrand factor in the haemostasis. Blood transfusion = Trasfusione del sangue. 2011 May;
[PubMed PMID: 21839029]
[3]
Bharati KP,Prashanth UR, Von Willebrand disease: an overview. Indian journal of pharmaceutical sciences. 2011 Jan
[PubMed PMID: 22131616]
Level 3 (low-level) evidence
[4]
Aliotta A,Bertaggia Calderara D,Zermatten MG,Marchetti M,Alberio L, Thrombocytopathies: Not Just Aggregation Defects-The Clinical Relevance of Procoagulant Platelets. Journal of clinical medicine. 2021 Feb 24;
[PubMed PMID: 33668091]
[5]
Mancini I,Baronciani L,Artoni A,Colpani P,Biganzoli M,Cozzi G,Novembrino C,Boscolo Anzoletti M,De Zan V,Pagliari MT,Gualtierotti R,Aliberti S,Panigada M,Grasselli G,Blasi F,Peyvandi F, The ADAMTS13-von Willebrand factor axis in COVID-19 patients. Journal of thrombosis and haemostasis : JTH. 2021 Feb;
[PubMed PMID: 33230904]
[7]
Lancellotti S,Sacco M,Basso M,De Cristofaro R, Mechanochemistry of von Willebrand factor. Biomolecular concepts. 2019 Nov 27;
[PubMed PMID: 31778361]
[8]
Terraube V,O'Donnell JS,Jenkins PV, Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance. Haemophilia : the official journal of the World Federation of Hemophilia. 2010 Jan;
[PubMed PMID: 19473409]
[9]
Pipe SW,Montgomery RR,Pratt KP,Lenting PJ,Lillicrap D, Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A. Blood. 2016 Oct 20;
[PubMed PMID: 27587878]
[10]
Itzhar-Baikian N,Boisseau P,Joly B,Veyradier A, Updated overview on von Willebrand disease: focus on the interest of genotyping. Expert review of hematology. 2019 Dec
[PubMed PMID: 31536379]
Level 3 (low-level) evidence
[11]
Randi AM,Smith KE,Castaman G, von Willebrand factor regulation of blood vessel formation. Blood. 2018 Jul 12;
[PubMed PMID: 29866817]
[13]
Palmer RL, Laboratory diagnosis of bleeding disorders. Basic screening tests. Postgraduate medicine. 1984 Dec;
[PubMed PMID: 6334288]
[14]
Hanby HA,Zheng XL, Current status in diagnosis and treatment of hereditary thrombotic thrombocytopenic purpura. Hereditary genetics : current research. 2014
[PubMed PMID: 25343060]
[16]
Joly BS,Coppo P,Veyradier A, An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura. Expert review of hematology. 2019 Jun;
[PubMed PMID: 31107120]
[18]
Scully M,Hunt BJ,Benjamin S,Liesner R,Rose P,Peyvandi F,Cheung B,Machin SJ,British Committee for Standards in Haematology., Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. British journal of haematology. 2012 Aug;
[PubMed PMID: 22624596]
[19]
Chen H,Fu A,Wang J,Wu T,Li Z,Tang J,Shen H,Zhu J,Li J,Zhu Q,Qing L, Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura. The Journal of international medical research. 2017 Jun;
[PubMed PMID: 28639502]
Level 2 (mid-level) evidence
[20]
Andrews RK,Berndt MC, Bernard-Soulier syndrome: an update. Seminars in thrombosis and hemostasis. 2013 Sep;
[PubMed PMID: 23929303]